Other Oncology
Product Highlights
- Detection of high-impact mutations across multiple solid tumour pathways
- Ultra-sensitive digital PCR performance for rare variant analysis
- Optimised for droplet digital platforms
- Supports biomarker discovery, resistance tracking, and longitudinal monitoring
- Custom singleplex and multiplex assay development available
Product Description
Our solid tumour assay portfolio spans key oncogenic drivers and resistance mutations across major cancer types, including EGFR, PIK3CA, KRAS, NRAS, ESR1, and HER2. These assays support translational research, therapy selection, and monitoring of treatment response. For applications requiring unique biomarkers or expanded panels, RainSure offers full custom assay development.
Available Assays
- EGFR Mutation Panel
- G465R
- G719A
- G719S
- E746_A750del (COSM6223)
- E746_A750del (COSM6225)
- E747_A750delinsP (COSM2338)
- E747_A750delinsP (COSM2339)
- L747_P753>S
- S768I
- V769_D770insASV
- D770_N771insG
- T790M
- C797S (COSMIC 6493937)
- C797S (COSMIC 5945664)
- L858R
- L861Q
PIK3CA – 11 Mutation Panel
- C420R
- E542K
- E545A
- E545D
- E545G
- E545K
- Q546E
- Q546R
- H1047L
- H1047R
- H1047Y
KRAS
- G12A
- G12C
- G12D
- G12S
- G12V
- G13D
NRAS
- G12V
- Q61R
ESR1
- Y537S
- D538G
HER2
- Copy Number Variation (CNV) Assay
